mirtazapine has been researched along with Syndrome in 4 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The authors report a case involving a 79-year-old woman with bipolar disorder, in whom Pisa syndrome occurred after introduction of mirtazapine, and completely disappeared 3 days after suspension of the drug." | 7.88 | Pisa syndrome associated with mirtazapine: a case report. ( Hirabayashi, N; Nakagome, K; Okazaki, M; Satake, N; Takano, H; Yamada, M; Yamada, Y, 2018) |
| " Based on the case report of a patient who developed mania with higher than recommended dosage of mirtazapine, we review the literature on the atypical nature of manic symptoms with mirtazapine." | 5.31 | Dysphoric mania induced by high-dose mirtazapine: a case for 'norepinephrine syndrome'? ( Bhanji, NH; Chouinard, G; Margolese, HC; Saint-Laurent, M, 2002) |
| "The authors report a case involving a 79-year-old woman with bipolar disorder, in whom Pisa syndrome occurred after introduction of mirtazapine, and completely disappeared 3 days after suspension of the drug." | 3.88 | Pisa syndrome associated with mirtazapine: a case report. ( Hirabayashi, N; Nakagome, K; Okazaki, M; Satake, N; Takano, H; Yamada, M; Yamada, Y, 2018) |
| " Based on the case report of a patient who developed mania with higher than recommended dosage of mirtazapine, we review the literature on the atypical nature of manic symptoms with mirtazapine." | 1.31 | Dysphoric mania induced by high-dose mirtazapine: a case for 'norepinephrine syndrome'? ( Bhanji, NH; Chouinard, G; Margolese, HC; Saint-Laurent, M, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamada, Y | 1 |
| Takano, H | 1 |
| Yamada, M | 1 |
| Satake, N | 1 |
| Hirabayashi, N | 1 |
| Okazaki, M | 1 |
| Nakagome, K | 1 |
| Chekroud, AM | 1 |
| Gueorguieva, R | 1 |
| Krumholz, HM | 1 |
| Trivedi, MH | 1 |
| Krystal, JH | 1 |
| McCarthy, G | 1 |
| Bhanji, NH | 1 |
| Margolese, HC | 1 |
| Saint-Laurent, M | 1 |
| Chouinard, G | 1 |
| Siddiqui, Z | 1 |
| Ramaswmay, S | 1 |
| Petty, F | 1 |
4 other studies available for mirtazapine and Syndrome
| Article | Year |
|---|---|
Pisa syndrome associated with mirtazapine: a case report.
Topics: Aged; Antidepressive Agents; Bipolar Disorder; Dystonia; Female; Humans; Mirtazapine; Syndrome | 2018 |
Reevaluating the Efficacy and Predictability of Antidepressant Treatments: A Symptom Clustering Approach.
Topics: Adolescent; Adult; Affect; Aged; Antidepressive Agents; Bupropion; Citalopram; Cluster Analysis; Dep | 2017 |
Dysphoric mania induced by high-dose mirtazapine: a case for 'norepinephrine syndrome'?
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Depressive Disorder; Dose-Respons | 2002 |
Mirtazapine for Charles Bonnet syndrome.
Topics: Antidepressive Agents, Tricyclic; Hallucinations; Humans; Male; Mianserin; Middle Aged; Mirtazapine; | 2004 |